Kikuchi, Japan

Hiroshi Nakatake

This inventor holds 10 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignees: Chemo-Sero-Therapeutic Research Institute, Isis Pharmaceuticals, Inc., Km Biologics Co., Ltd.. Active years: 1991-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Nakatake. Retrieved from https://idiyas.com/inventor/hiroshi-nakatake-uxr06kat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 60.0



Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 240(Granted Patents)


Location History:

  • Kumamoto, JP (1991)
  • Kikuyo-machi, JP (2001 - 2002)
  • Kumamoto-ken, JP (2009)
  • Kikuchi, JP (2012 - 2014)
  • Koshi, JP (2020)

Company Filing History:


Years Active: 1991-2020

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of Hiroshi Nakatake

Introduction

Hiroshi Nakatake is a prominent inventor based in Kikuchi, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of methods related to matrix metalloproteinases. With a total of 10 patents to his name, Nakatake's work has had a considerable impact on pharmaceutical research and development.

Latest Patents

Nakatake's latest patents include a method for monomerizing matrix metalloproteinase 7 (MMP-7) aggregates. This innovative method involves treating MMP-7 aggregates with a buffer solution containing a monovalent cation chloride at a low concentration or using a buffer solution that does not contain such cations. Additionally, he has developed a process for preparing inclusion body-forming proteins, which includes a nucleic acid fragment coding for a modified alkaline phosphatase signal peptide. This process is crucial for the production of proteins of interest in various applications.

Career Highlights

Throughout his career, Nakatake has worked with notable organizations such as the Chemo-Sero-Therapeutic Research Institute and Isis Pharmaceuticals, Inc. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in his field.

Collaborations

Nakatake has collaborated with esteemed colleagues, including Chikateru Nozaki and Tatsuo Eto. These partnerships have fostered a collaborative environment that has led to innovative solutions in biochemistry.

Conclusion

Hiroshi Nakatake's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence pharmaceutical research and development, showcasing the importance of innovation in science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…